Article
Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework.
Journal of clinical microbiology - 28 Jan 2020
Bonde Jesper Hansen, Pedersen Helle, Quint Wim, Xu Lan, Arbyn Marc, Ejegod Ditte Møller
Abstract excerpt
The Validation of HPV Genotyping Tests (VALGENT) framework is an international cooperation designed to evaluate human papillomavirus (HPV) assays with genotyping capabilities. Here, we assessed the performance of the BD Onclarity assay using Danish SurePath cervical screening samples collected under the fourth VALGENT installment, consisting of 998 consecutive samples from a screening population and 297 enriched...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.